A slew of new studies and reports suggest that new molecular approaches may soon help reduce the global burden of tuberculosis.

Roche will receive rights to at least 1 billion lateral flow tests annually from Sapphiros as well as access to the company's future molecular testing technology.

The company intends to focus on custom partnerships around stroke, cancer, cardiovascular diseases and neurodegenerative diseases.

Last week, readers were most interested in a story about Labcorp's acquisition of certain lab assets of Parkview Health, which serves patients in Indiana and northwest Ohio.

At the Association for Molecular Pathology annual meeting in Boston, stakeholders discussed regulatory and legislative priorities for the coming year.

Given the amount of tests that have required certification under the new system, the EU has staggered the grace periods for different classes of devices already holding CE-IVD marks obtained under the ...

Labcorp will acquire outreach labs serving patients in Indiana and northwest Ohio while Parkview will continue to operate labs serving acute and emergency needs.

The updated CE marking now enables labs in Europe to unify their workflows for both cell and tissue slide imaging and processing.

Legislation passed by the US Senate to reopen the federal government includes a temporary delay to price cuts and data reporting requirements.

Revenues from the Life Sciences business unit, which is on track to be sold to Waters in Q1 2026, rose 2 percent to $1.37 billion.

NEW YORK – Precision oncology firm Personalis announced on Monday that its NeXT Personal test for minimal residual disease has received coverage from the US Centers for Medicare and Medicaid Services ...